News October 7, 2025 GEMMABio Launches Rare Therapeutics, Inc. to Develop and Deliver Gene Therapies for Ultra‑Orphan Diseases Press Release Jim Wilson's Gemma Bio spins out RareTx to scale gene therapy for ultra-orphan diseases News July 11, 2025 ‘The Responsible Development of Adeno-Associated Virus Gene Therapies’A commentary by Drs. Jim Wilson and Art Caplan published in Human Gene Therapy Read now Download PDF July 7, 2025 Jim Wilson's Gemma Bio enters into its second international gene therapy partnership News July 5, 2025 Abu Dhabi to partner with GEMMABio Therapeutics, advance gene therapies for children with spinal muscular atrophy News June 30, 2025 'We can't waste money': Dr. James Wilson believes gene therapy needs a new business model News May 27, 2025 Geneticist Jim Wilson left UPenn behind, but not his dream of curing rare genetic diseases News January 27, 2025 GEMMABio rakes in $34M raise, a huge boost to the Philly life sciences scene News January 9, 2025 Gene Therapy Pioneer Jim Wilson Comments on iECURE's Announcement of Complete Clinical Response for ECUR-506 Press Release January 8, 2025 GEMMABio Appoints Dr. May Orfali as Chief Medical Officer Press Release Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment Press Release December 24, 2024 UPenn gene therapy pioneer’s biotech gets $34 million in funding News Jim Wilson secures $100M for global approach aimed at reviving gene therapy field News December 23, 2024 GEMMABio Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements Press Release GEMMABio Announces $100 Million Agreement with Brazil's Leading Health Research Institute October 8, 2024 Press Release July 31, 2024 To Further Advance Gene Therapy Research, Industry Pioneer Jim Wilson is Forming Two Independent Companies Dedicated to Genetic Medicine Press Release
